288 related articles for article (PubMed ID: 14528298)
1. G13 is an essential mediator of platelet activation in hemostasis and thrombosis.
Moers A; Nieswandt B; Massberg S; Wettschureck N; Grüner S; Konrad I; Schulte V; Aktas B; Gratacap MP; Simon MI; Gawaz M; Offermanns S
Nat Med; 2003 Nov; 9(11):1418-22. PubMed ID: 14528298
[TBL] [Abstract][Full Text] [Related]
2. Anti-glycoprotein VI treatment severely compromises hemostasis in mice with reduced alpha2beta1 levels or concomitant aspirin therapy.
Grüner S; Prostredna M; Aktas B; Moers A; Schulte V; Krieg T; Offermanns S; Eckes B; Nieswandt B
Circulation; 2004 Nov; 110(18):2946-51. PubMed ID: 15505105
[TBL] [Abstract][Full Text] [Related]
3. G13-mediated signaling as a potential target for antiplatelet drugs.
Moers A; Wettschureck N; Offermanns S
Drug News Perspect; 2004 Oct; 17(8):493-8. PubMed ID: 15605108
[TBL] [Abstract][Full Text] [Related]
4. Costimulation of Gi- and G12/G13-mediated signaling pathways induces integrin alpha IIbbeta 3 activation in platelets.
Nieswandt B; Schulte V; Zywietz A; Gratacap MP; Offermanns S
J Biol Chem; 2002 Oct; 277(42):39493-8. PubMed ID: 12183468
[TBL] [Abstract][Full Text] [Related]
5. Activation of platelet function through G protein-coupled receptors.
Offermanns S
Circ Res; 2006 Dec; 99(12):1293-304. PubMed ID: 17158345
[TBL] [Abstract][Full Text] [Related]
6. Platelets possess and require an active protein palmitoylation pathway for agonist-mediated activation and in vivo thrombus formation.
Sim DS; Dilks JR; Flaumenhaft R
Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1478-85. PubMed ID: 17303775
[TBL] [Abstract][Full Text] [Related]
7. The role of heterotrimeric G proteins in platelet activation.
Offermanns S
Biol Chem; 2000; 381(5-6):389-96. PubMed ID: 10937869
[TBL] [Abstract][Full Text] [Related]
8. Importance of platelet phospholipase Cgamma2 signaling in arterial thrombosis as a function of lesion severity.
Nonne C; Lenain N; Hechler B; Mangin P; Cazenave JP; Gachet C; Lanza F
Arterioscler Thromb Vasc Biol; 2005 Jun; 25(6):1293-8. PubMed ID: 15774906
[TBL] [Abstract][Full Text] [Related]
9. PI 3-kinase p110beta: a new target for antithrombotic therapy.
Jackson SP; Schoenwaelder SM; Goncalves I; Nesbitt WS; Yap CL; Wright CE; Kenche V; Anderson KE; Dopheide SM; Yuan Y; Sturgeon SA; Prabaharan H; Thompson PE; Smith GD; Shepherd PR; Daniele N; Kulkarni S; Abbott B; Saylik D; Jones C; Lu L; Giuliano S; Hughan SC; Angus JA; Robertson AD; Salem HH
Nat Med; 2005 May; 11(5):507-14. PubMed ID: 15834429
[TBL] [Abstract][Full Text] [Related]
10. Platelet chemokines and chemokine receptors: linking hemostasis, inflammation, and host defense.
Gear AR; Camerini D
Microcirculation; 2003 Jun; 10(3-4):335-50. PubMed ID: 12851650
[TBL] [Abstract][Full Text] [Related]
11. Deficiency or inhibition of Gas6 causes platelet dysfunction and protects mice against thrombosis.
Angelillo-Scherrer A; de Frutos P; Aparicio C; Melis E; Savi P; Lupu F; Arnout J; Dewerchin M; Hoylaerts M; Herbert J; Collen D; Dahlbäck B; Carmeliet P
Nat Med; 2001 Feb; 7(2):215-21. PubMed ID: 11175853
[TBL] [Abstract][Full Text] [Related]
12. Par4 is required for platelet thrombus propagation but not fibrin generation in a mouse model of thrombosis.
Vandendries ER; Hamilton JR; Coughlin SR; Furie B; Furie BC
Proc Natl Acad Sci U S A; 2007 Jan; 104(1):288-92. PubMed ID: 17190826
[TBL] [Abstract][Full Text] [Related]
13. Characteristic defects in neural crest cell-specific Galphaq/Galpha11- and Galpha12/Galpha13-deficient mice.
Dettlaff-Swiercz DA; Wettschureck N; Moers A; Huber K; Offermanns S
Dev Biol; 2005 Jun; 282(1):174-82. PubMed ID: 15936338
[TBL] [Abstract][Full Text] [Related]
14. Defective platelet activation in G alpha(q)-deficient mice.
Offermanns S; Toombs CF; Hu YH; Simon MI
Nature; 1997 Sep; 389(6647):183-6. PubMed ID: 9296496
[TBL] [Abstract][Full Text] [Related]
15. The G protein G alpha(13) is required for growth factor-induced cell migration.
Shan D; Chen L; Wang D; Tan YC; Gu JL; Huang XY
Dev Cell; 2006 Jun; 10(6):707-18. PubMed ID: 16740474
[TBL] [Abstract][Full Text] [Related]
16. Signaling through G(alpha)13 switch region I is essential for protease-activated receptor 1-mediated human platelet shape change, aggregation, and secretion.
Huang JS; Dong L; Kozasa T; Le Breton GC
J Biol Chem; 2007 Apr; 282(14):10210-22. PubMed ID: 17298951
[TBL] [Abstract][Full Text] [Related]
17. Effects of microgravity and hypergravity on platelet functions.
Dai K; Wang Y; Yan R; Shi Q; Wang Z; Yuan Y; Cheng H; Li S; Fan Y; Zhuang F
Thromb Haemost; 2009 May; 101(5):902-10. PubMed ID: 19404544
[TBL] [Abstract][Full Text] [Related]
18. Socius, a novel binding partner of Galpha12/13, promotes the Galpha12-induced RhoA activation.
Tateiwa K; Katoh H; Negishi M
Biochem Biophys Res Commun; 2005 Nov; 337(2):615-20. PubMed ID: 16202387
[TBL] [Abstract][Full Text] [Related]
19. Unresponsiveness of platelets lacking both Galpha(q) and Galpha(13). Implications for collagen-induced platelet activation.
Moers A; Wettschureck N; Grüner S; Nieswandt B; Offermanns S
J Biol Chem; 2004 Oct; 279(44):45354-9. PubMed ID: 15326177
[TBL] [Abstract][Full Text] [Related]
20. The paradox of platelet activation and impaired function: platelet-von Willebrand factor interactions, and the etiology of thrombotic and hemorrhagic manifestations in essential thrombocythemia and polycythemia vera.
Michiels JJ; Berneman Z; Schroyens W; Finazzi G; Budde U; van Vliet HH
Semin Thromb Hemost; 2006 Sep; 32(6):589-604. PubMed ID: 16977569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
